1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Creo Medical Limited
  6. News
  7. Summary
    CREO   GB00BZ1BLL44

CREO MEDICAL LIMITED

(CREO)
  Report
Delayed London Stock Exchange  -  11:35 2022-06-24 am EDT
91.00 GBX    0.00%
05/26Creo Medical Limited Reports Earnings Results for the Full Year Ended December 31, 2021
CI
05/23Creo Medical Signs Collaboration With Intuitive Surgical
DJ
04/28Creo Medical Group plc Provides Revenue Guidance for the Year Ended 31 December 2021
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Creo Medical Signs Collaboration With Intuitive Surgical

05/23/2022 | 02:46am EDT

By Kyle Morris


Creo Medical Group PLC said Monday that it has signed a long-term, multiyear collaboration agreement for the use of its technology with Intuitive Surgical Inc.'s robot-assisted surgical platform.

The London-listed medical-device company said that the collaboration provides a framework for joint clinical studies and includes milestone payments and royalty structures for any products which may be sold in the future.

Shares in Creo at 0822 GMT were up 2.00 pence, or 2.1%, at 98.00 pence.


Write to Kyle Morris at kyle.morris@dowjones.com


(END) Dow Jones Newswires

05-23-22 0446ET

Stocks mentioned in the article
ChangeLast1st jan.
CREO MEDICAL LIMITED 0.00% 91 Delayed Quote.-38.93%
INTUITIVE SURGICAL, INC. 2.53% 209.67 Delayed Quote.-41.64%
All news about CREO MEDICAL LIMITED
05/26Creo Medical Limited Reports Earnings Results for the Full Year Ended December 31, 2021
CI
05/23Creo Medical Signs Collaboration With Intuitive Surgical
DJ
04/28Creo Medical Group plc Provides Revenue Guidance for the Year Ended 31 December 2021
CI
04/20Creo Medical Group plc Announces Officially Opened Its Regional Hub in Singapore
CI
02/03Creo Medical Group plc Provides Revenue Guidance for the Year Ending December 31, 2021
CI
01/24Creo Medical Inks Heads of Terms Deals with Partners in Related Markets
MT
2021FTSE Down, Redrow Gains After AGM Update; Shares Look Attractive
DJ
2021Creo Medical Buys Fiber Product Manufacturer Aber
MT
2021Creo Medical Limited acquired Aber Electronics Limited for £1.4 million.
CI
2021IQ Endoscopes Limited announced that it has received ?4 million in funding from Develop..
CI
More news
Financials
Sales 2022 26,7 M 32,8 M 32,8 M
Net income 2022 -22,9 M -28,1 M -28,1 M
Net cash 2022 17,6 M 21,6 M 21,6 M
P/E ratio 2022 -7,34x
Yield 2022 -
Capitalization 144 M 177 M 177 M
EV / Sales 2022 4,73x
EV / Sales 2023 4,92x
Nbr of Employees 290
Free-Float 80,7%
Chart CREO MEDICAL LIMITED
Duration : Period :
Creo Medical Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CREO MEDICAL LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 91,00 GBX
Average target price 250,00 GBX
Spread / Average Target 175%
EPS Revisions
Managers and Directors
Craig Jonathan Gulliford Chief Executive Officer & Director
Richard Rees Chief Financial Officer & Director
Charles Alexander Evan Spicer Non-Executive Chairman
Christopher Paul Hancock Director & Chief Technology Officer
Steven Morris Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
CREO MEDICAL LIMITED-38.93%177
NOVOCURE LIMITED0.69%7 907
MASIMO CORPORATION-53.68%7 693
SHOCKWAVE MEDICAL, INC.10.86%7 076
GETINGE AB-41.69%6 197
PENUMBRA, INC.-54.15%4 964